ANNUAL LEAVE AND SPECIAL LEAVE POLICY - …

Annual Leave and Special Leave Policy V3 - 2 - November 2015 DOCUMENT CONTROL Reference JT/Sep/12/AL&SLP Version 3 Status Final …

  Policy, Annual, Special, Leave, Annual leave and special leave policy

RECORD KEEPING AND RECORDS MANAGEMENT …

Record Keeping and Records Management Policy V5 3 August 2015 CONTENTS Section Summary of Section Page Doc 2Document Control Cont Contents 3 1 Introduction 4 2 5Purpose & Scope

  Policy, Management, Record, Keeping, Scopes, Record keeping and records management, Record keeping and records management policy

CLINICAL SUPERVISION POLICY - sompar.nhs.uk

Clinical Supervision Policy V6 - 4 - March 2016 1. INTRODUCTION 1.1 One of the most important influences on the quality of service is the

  Policy, Quality, Clinical, Supervision, Clinical supervision policy

LONE WORKING POLICY - sompar.nhs.uk

Lone Working Policy V4 - 2 - August 2016 DOCUMENT CONTROL Reference AS//Aug16/LWP Version 4 Status Final Author Head of Corporate Business

  Policy, Working, Lone, Lone working policy

SEARCHING MENTAL HEALTH INPATIENTS, …

Search of Patient, Persons or Property Policy V3 - 1 - August 2015 SEARCHING MENTAL HEALTH INPATIENTS, VISITORS AND PERSONAL PROPERTY POLICY

  Health, Property, 2015, Personal, Mental, Searching, Visitors, Inpatient, Searching mental health inpatients, 2015 searching mental health inpatients, Visitors and personal property

FOOD HYGIENE POLICY - sompar.nhs.uk

Food Hygiene Policy -6- April 2015 V2 Secondary Food Handlers 4.2 A secondary food handler is a person who is involved in the service of food items

  Policy, Food, Hygiene, Food hygiene policy

Version 3.1 Retirement Policy - sompar.nhs.uk

Retirement Policy V7 - 6 - June 2016 5.3 Planned Retirement Date (PRD) is either the ‘normal retirement age’ or the date at which you choose ‘voluntary early retirement’.

  Policy, Early, Retirement, Retirement policy, Early retirement

SICKNESS ABSENCE MANAGEMENT - sompar.nhs.uk

Managing Sickness Policy V4 - 1 - August 2015 SICKNESS ABSENCE MANAGEMENT Version: 4 Ratified by: Senior Managers Operational Group Date ratified: August 2015

  Management, Absence, Sickness, Sickness absence management

LONG SERVICE AWARDS POLICY - sompar.nhs.uk

Long Service Awards V5 - 5 - May 2017 • Staff should follow the guidance contained within this policy if they wish to apply for a Long Service Award. • It is the employee’s responsibility to provide documented evidence of

  Policy, Services, Long, Awards, Promass, Long service awards policy

Low FODMAP Diet for Irritable Bowel Syndrome (IBS)

FACT SHEET - Dietetics The Low FODMAP diet is extremely effective in improving the symptoms in approximately 70% of patients with IBS. However it is a complex diet …

  Diet, Fodmap, Low fodmap diet for

VELCADE (bortezomib) for Subcutaneous …

Injection number Date Comments 1 2 3 4 5 6 7 8 9 10 11 12 VELCADE® (bortezomib) for Subcutaneous Administration Site Tracker This diagram illustrates appropriate sites for subcutaneous administration of VELCADE (bortezomib).

  Administration, Site, Subcutaneous, Bortezomib, Velcade, For subcutaneous, For subcutaneous administration site

How to administer intramuscular and subcutaneous …

How to Administer Intramuscular and Subcutaneous Vaccine Injections . Administer these vaccines . via IM route • Diphtheria-tetanus-pertussis (DTaP,

  Subcutaneous

How to administer intramuscular and subcutaneous …

How to Administer Intramuscular and Subcutaneous . Vaccine Injections to Adults. Intramuscular (IM) Injections. Administer these vaccines via IM route

  Subcutaneous

Guidelines for the Use of Subcutaneous …

1 Guidelines for the Use of Subcutaneous Medications in Palliative Care Dec 2009 Review Dec 2011

  Care, Medication, Palliative, Subcutaneous, Of subcutaneous medications in palliative care

The PATH study - CIDP Treatment With …

1 Hizentra CIDP (PATH) – IgPro20_3003 K. Goodwin 21 Nov. 2012 The PATH study - CIDP Treatment With Subcutaneous Immunoglobulin (IgPro20) CSL Behring is currently recruiting patients for the PATH study, an international clinical

  With, Treatment, Subcutaneous, Immunoglobulin, Ipdc, Cidp treatment with subcutaneous immunoglobulin, Igpro20

NEW ZEALAND DATA SHEET - Medsafe

Zoladex 10.8 mg Data Sheet 280218 Copyright 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME ZOLADEX 10.8 mg Depot Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ...